Rosacea is in the eye of the beholder, expert says

As for treating papules and pustules with oral agents, the strongest evidence favors oral tetracyclines and isotretinoin.

Topical options for acne patients continue to expand

In 2020, clascoterone cream became the first topical androgen receptor inhibitor approved for the treatment of acne in patients aged 12 years and older.

Infantile hemangiomas: Accurate diagnosis is crucial

Consider propranolol a “life changer” in extreme cases.

Managing hyperhidrosis, HS: Ask questions first

Ask the patient a simple question: “What bothers you the most?”

Recent psoriasis pathophysiology insights carry treatment implications

“The primary problem in psoriasis is not so much the inflammatory activity, but the ability to turn off the activity.”

Neoadjuvant immunotherapy shows promise in stage III melanoma

There is both preclinical and clinical evidence that neoadjuvant therapy may offer a survival advantage over adjuvant therapy.

Hypochlorous acid is a valuable adjunctive treatment in AD

Stabilized topical hypochlorous acid has potent antimicrobial and antipruritic effects.

Deucravacitinib offers biologic-like psoriasis efficacy in oral form

Novel anti-inflammatory mechanism involves selective TYK2 inhibition.

Telltale dermoscopic features of melanomas lacking pigment reviewed

Investigators developed a simple, eight-variable model, which demonstrated a sensitivity of 70% and specificity of 56% for diagnosis of melanoma.

New AK treatments: Local reactions are the price for greater clearance rates

Like current treatments effective for actinic keratosis, coming therapies are likely to trade tolerability for efficacy.

Pages